3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
2
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Prostatic Neoplasms
22
Breast Neoplasms
6
Sleep Wake Disorders
1
Sarcoma, Ewing
1
Sarcoma
1
Prostate Adenocarcinoma
1
Polycystic Ovary Syndrome
1
Osteosarcoma
1
Lymphoma
1
Infertility
1
Hematopoietic and Lymphatic System Neoplasm
1
Fatigue
1
Interventions
Cyclophosphamide
60
Vincristine
57
Doxorubicin
54
Rituximab
48
Prednisone
44
Etoposide
35
Radiotherapy
34
Cytarabine
26
Filgrastim
22
Methotrexate
21
Bleomycin
21
Dexamethasone
18
Peripheral Blood Stem Cell Transplantation
14
Carmustine
14
Vinblastine
13
Prednisolone
13
VAP-cyclo protocol
12
Melphalan
12
Mitoxantrone
11
Mercaptopurine
10
Leucovorin
10
Dacarbazine
9
Ifosfamide
8
Granulocyte Colony-Stimulating Factor
8
Procarbazine
7
Methylprednisolone
7
Lenalidomide
7
Gemcitabine
7
Daunorubicin
7
Cisplatin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Lymphoma
×
Triptorelin Pamoate
×
Clear all
NCT05328258
2023-10-27
ProFertil
Karolinska University Hospital
Phase 3
Recruiting
500 enrolled